GT Biopharma, Inc. (GTBP)
0.6773
+0.04
(+5.83%)
USD |
NASDAQ |
Dec 10, 14:27
GT Biopharma Free Cash Flow: -11.36M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Plus Therapeutics, Inc. | -15.78M |
| Geron Corp. | -132.68M |
| Regeneron Pharmaceuticals, Inc. | 3.881B |
| SELLAS Life Sciences Group, Inc. | -30.62M |
| Xencor, Inc. | -137.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -3.677M |
| Cash from Financing (Quarterly) | 0.977M |
| Free Cash Flow Per Share (Quarterly) | -0.9331 |
| Free Cash Flow to Equity (Quarterly) | -3.677M |
| Free Cash Flow to Firm (Quarterly) | -3.677M |
| Free Cash Flow Yield | -594.2% |